Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 15 to 23 amino acid residues in defined sequence
Reexamination Certificate
2005-08-16
2005-08-16
Kemmerer, Elizabeth (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
15 to 23 amino acid residues in defined sequence
C530S300000, C435S810000, C435S975000, C514S013800, C514S014800
Reexamination Certificate
active
06930168
ABSTRACT:
The invention provides peptide compositions and methods of making and using therapeutic compositions comprising peptides for the treatment of a subject having a demyelinating condition.
REFERENCES:
patent: 5614192 (1997-03-01), Vandenbark
patent: 5827516 (1998-10-01), Urban et al.
patent: 5880103 (1999-03-01), Urban et al.
patent: 6509033 (2003-01-01), Urban et al.
patent: 2003/0103993 (2003-06-01), Deshpande et al.
patent: 2004/0038887 (2004-02-01), Strominger et al.
patent: WO 02/057291 (1994-03-01), None
patent: WO 94/04171 (2002-07-01), None
Fridkis-Hareli et al. Novel synthetic amino acid copolymers that inhibit autoantigen-Specific T cell responses and suppress experimental autoimmune encephalomyelitis. J Clin Invest 109(12): 1635-1643, 2002.
Stern et al. Peptide 15-mers of defined sequence that substitute for random amino acid copolymers in amelioration of experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 102(5): 1620-1625, 2005.
Esposito et al. (1999).J. Immunol.163: 4027-4032.
Fridkis-Harell et al. (1999).J. Immunol.162: 4697-4704.
Fridkis-Harell et al. (2001).Human Immunology. 62: 753-763.
Kawamura et al. (2000).J. Clin. Invest.105: 977-984.
Li et al (2000).J. Mol. Biol.304: 177-188.
Smith et al. (1998).J. Exp. Med.188: 1511-1520.
Mukku et al. (1995).Molecular Immunol. 32: 555-564.
Wiertz et al. (1993).Eur. J. Immunol.23: 232-239.
Fridkis-Hareli Masha
Strominger Jack L.
Bunner Bridget E.
Guterman, Esq. Sonia K.
Kemmerer Elizabeth
Lawson & Weitzen, LLP
The President and Fellows of Harvard College
LandOfFree
Synthetic peptides for demyelinating conditions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic peptides for demyelinating conditions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic peptides for demyelinating conditions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3507454